Study types
- article 2
- other 2
- review 1
Condition tags
- endometriosis 4
Top journals
Frequent coauthors
- R. Jeffrey Chang 5
- Howard L. Judd 3
- John Lu 3
- David R. Meldrum 3
- Meldrum DR 3
- Judd HL 3
- Rivier J 2
- J. Rivier 2
- Lu JK 2
- Vale W 2
Clinical application of exogenous hormone as a method of contraception and/or treatment of various gynecologic disorders is exceedingly common. Unfortunately, the concurrent use of these agents also complicates the interpretation of patholo…
Previously, we reported that short term administration of a highly potent GnRH agonist (GnRHa) for 1 month to patients with polycystic ovarian disease (PCO) resulted in complete suppression of ovarian steroidogenesis without measurable effe…
In eumenorrheic women with endometriosis and in oligo-amenorrheic women with polycystic ovarian disease (PCO), chronic administration of a long-acting GnRH agonist (GnRH-a) reduced the circulating concentrations of estrogens and androgens t…
Five women with endometriosis were given a daily dose of a potent long-acting GnRH agonist, D-Trp6-Pro9-Net-LHRH (GnRH-A) for 28 days in an attempt to suppress ovarian estrogen secretion. The mean level of estradiol (E2) during sampling ove…